PHKA2 and neoplasm: On the other hand, pretreatment with AG17 (PDGFR-TK) and HNMPA (IGFR-TK) had no effect on the tumor uptake of [125I]PYK; however, VEGFR inhibitor I was found to decrease its tumor uptake.